[Oxaliplatin-induced peripheral neuropathy: how to create a barrier?]

[1]  X. Navarro,et al.  Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies , 2019, Experimental Neurology.

[2]  B. Ehrlich,et al.  Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. , 2019, Critical reviews in oncology/hematology.

[3]  F. Bosco,et al.  The Role of Endothelial Dysfunction in Peripheral Blood Nerve Barrier: Molecular Mechanisms and Pathophysiological Implications , 2019, International journal of molecular sciences.

[4]  L. Colvin Chemotherapy-induced peripheral neuropathy: where are we now? , 2019, Pain.

[5]  T. Jensen,et al.  Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy , 2019, Front. Neurosci..

[6]  K. Taguchi,et al.  Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity , 2017, Neuropeptides.

[7]  Preti Jain,et al.  The Human Blood-Nerve Barrier Transcriptome , 2017, Scientific Reports.

[8]  G. Ciarimboli,et al.  Role of transporters in the distribution of platinum-based drugs , 2015, Front. Pharmacol..

[9]  Gillian L. Currie,et al.  Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis , 2014, PAIN®.

[10]  A. Shields,et al.  Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2 , 2013, Proceedings of the National Academy of Sciences.

[11]  C. Shapiro,et al.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. , 2013, JAMA.

[12]  A. Windebank,et al.  Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. , 2012, Neuro-oncology.

[13]  T. Hambley,et al.  Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs , 2000, British Journal of Cancer.